Results 201 to 210 of about 87,183 (321)
Timeline of the patient's clinical course from birth to follow‐up: (birth, diagnosis, NICU admission, prostaglandin infusion, surgery date, post‐op NICU stay, discharge and 3 month follow‐up). ABSTRACT Patients with Tetralogy of Fallot (TOF) with pulmonary atresia present high perioperative risks during non‐cardiac surgeries, making anesthetic ...
Prince Barnawal +4 more
wiley +1 more source
A dataset of heart sound regurgitation of patients with heart valve disorders. [PDF]
Fraiwan M, Ibnian A, Haider NS.
europepmc +1 more source
Bilateral Vocal Cord Paralysis Following Influenza A: Case Report
Flexible nasal endoscopy demonstrating bilateral vocal cord paralysis (BVCP) in the paramedian position. The left image demonstrates a glottic gap between the vocal cords (white arrows) in the maximally adducted position (patient saying “eeee”). Under normal circumstances the vocal cords should be touching with no glottic gap. The right image shows his
Dan H. V. Tran +10 more
wiley +1 more source
Sounding Interiors: Daydream, Imagination, and the Auscultation of Domestic Space
Andrew Czink
openalex +2 more sources
Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy [PDF]
Borgeat, K A +4 more
core +1 more source
Silicosis Diagnosed Using Transbronchial Lung Biopsy: The Pivotal Role of Occupational History
ABSTRACT Pulmonary silicosis, a preventable occupational lung disease caused by chronic inhalation of crystalline silica dust in industries like construction, mining, and stone masonry, remains underdiagnosed in TB‐endemic regions due to overlapping clinical and radiological features.
Boon Hau Ng +6 more
wiley +1 more source
Acute pulmonary edema following appendectomy under general anesthesia: A case report. [PDF]
Qu Y, Li D, Li S, He Y.
europepmc +1 more source
Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari +4 more
wiley +1 more source

